Who is sponsoring NCT02621463?

NCT02621463 is sponsored by University of Utah.

What drugs are being tested in NCT02621463?

Interventions in NCT02621463: Noninvasive Ventilator (V60, Philips).

What condition does NCT02621463 study?

NCT02621463 studies Apnea During Procedural Sedation.

Is NCT02621463 still recruiting?

NCT02621463 is currently completed. Last updated 27 April 2021.

Are results published for NCT02621463?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2021-04-27 · How we verify

NCT02621463

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Electric Blower Based Ventilator Used During Procedural Sedation

Completed NA Results posted Last updated 27 April 2021

What this trial tests

NA trial testing Noninvasive Ventilator (V60, Philips) in Apnea During Procedural Sedation in 29 participants. Completed in 1 June 2019.

Timeline

1 December 2015

Primary endpoint
1 June 2019

1 June 2019

Quick facts

Lead sponsor	University of Utah
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	29
Start date	1 December 2015
Primary completion	1 June 2019
Estimated completion	1 June 2019

Drugs / interventions tested

Noninvasive Ventilator (V60, Philips)

Conditions studied

Apnea During Procedural Sedation — all drugs for Apnea During Procedural Sedation →

Sponsor

University of Utah

Who can join

18 and older, any sex, with Apnea During Procedural Sedation. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Percentage of Time the Patient Will Experience Apnea Primary · Duration of Diagnostic Procedure (Colonoscopy)

Length of time in minutes the patient experiences apnea divided by the length of time of the diagnostic procedure (Unit: %)

Group	Value	95% CI
Noninvasive Ventilation	11	4 – 22

Sponsor's own description

Conduct human trials in the endoscopy suite of our continuous positive airway pressure (CPAP) ventilator approach using an FDA approved ventilator.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Utah trials

Trials by the same sponsor.

NCT07515755 — Supplemental Oxygen and Oxygen Desaturations in Colonoscopies · NA · not yet recruiting
NCT07225426 — Personalizing Financial Incentives · NA · recruiting
NCT06716411 — Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness · NA · recruiting
NCT07246538 — Positive Airway Pressure (PAP) System Evaluation in Volunteers · NA · not yet recruiting
NCT04208984 — Diversion Device With Breath Control · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02621463 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Utah
Last refreshed: 27 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02621463.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing